NOVAVAX INC Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Novavax Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2025.
- Novavax Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $946K, a 57.1% decline year-over-year.
- Novavax Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was $8.56M, a 56.9% increase year-over-year.
- Novavax Inc annual Income Tax Expense (Benefit) for 2024 was $10.9M, a 436% increase from 2023.
- Novavax Inc annual Income Tax Expense (Benefit) for 2023 was $2.03M, a 52.7% decline from 2022.
- Novavax Inc annual Income Tax Expense (Benefit) for 2022 was $4.29M, a 85.3% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)